The US Food and Drug Administration (FDA) has approved lunsotogene parvec-cwha (Otarmeni), the first gene therapy for genetic ...
Antibiotics dominate early care: More than half of pediatric patients received combination systemic antibiotics and topical therapies as first-line treatment, while biologic use remained low.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results